article thumbnail

Medicaid Often Restricts Access to Heart-Protective Diabetes Agents

Med Page Today

(MedPage Today) -- Medicaid plans often put up barriers around newer classes of diabetes medications that offer cardioprotection, according to a national study of formulary policies as of March 2024. Mainly driven by restrictive formulary policies.

article thumbnail

Trends in direct health care costs among US adults with atherosclerotic cardiovascular disease with and without diabetes

Cardiovascular Diabetology

Objective Population-based national data on the trends in expenditures related to coexisting atherosclerotic cardiovascular diseases (ASCVD) and diabetes is scarce. Individuals with diabetes had a 1.5-fold fold higher mean expenditure that those without diabetes. individuals aged ≥ 18 years.

article thumbnail

How to Get Free or Lower Cost Insulin for Your Medicare and Non-Medicare Patients: Shattering Barriers to Insulin Access

Cardiometabolic Health Congress

Astronomically high insulin costs have led to complications and barriers to access for millions of Americans with diabetes. Please advise your Medicaid patients to check their state’s Medicaid agency for specific information, as every state’s regulations differ. Get more information on Medicaid insulin benefits.

article thumbnail

Healthcare Access and Cardiovascular Risk Factor Management Among Working-Age US Adults During the Pandemic

Circulation: Cardiovascular Quality & Outcomes

We then evaluated changes among low-income adults in Medicaid expansion versus non-expansion states using a similar approach.Results:The unweighted study population included 80,767 low-income and 184,136 high income adults. 0.96]) decreased for low-income adults, while diabetes screening (RR 1.01 [0.95-1.08]) 1.08]) remained stable.

article thumbnail

Weight Loss Drugs Land Medicare Coverage for Cardiovascular Events

CardiacWire

Medicare Part D already covered diabetes-targeted GLP-1s (Ozempic & Mounjaro), and this guidance paves the way for on-label coverage for their obesity counterparts.

article thumbnail

Abstract WP48: Prescription Rate for Antihyperglycemic Medication With Proven Cardiovascular Benefit at Discharge in Stroke Patients Not Equal Among Payer Sources

Stroke Journal

Background:Mortality doubles in stroke patients when Diabetes Mellitus (DM) is present. Payer sources were identified as: self-pay, Medicaid, Medicare, and Private/HMO. Medicaid, and 15.3% Stroke, Volume 55, Issue Suppl_1 , Page AWP48-AWP48, February 1, 2024. Findings: In the specified timeframe, 11.7% of patients received AMPB.

Stroke 40
article thumbnail

Abstract WP137: 10-Year Trends in Last Known Well to Arrival Time in Acute Ischemic Stroke Patients: 2014-2023

Stroke Journal

1.39]), Medicaid insurance (1.16 [1.06-1.27]), 1.66]), and comorbidities of diabetes (1.29 [1.18-1.41]), groups were more likely to be older, males, Black or Asian race, Medicaid insurance, lower income, and more comorbidities. The AIS patients in the LKWA>4.5 1.32]), males (1.10 [1.03-1.17]), 1.17]), Black (1.20 [1.08-1.33]),